- Home
- MMA vs XLO Comparison
MMA vs XLO Comparison
Compare MMA & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMA | XLO |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2M | 41.8M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MMA | XLO |
|---|---|---|
| Price | $1.22 | $0.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 115.6K | ★ 514.3K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $739,641.00 | ★ $31,804,000.00 |
| Revenue This Year | N/A | $626.78 |
| Revenue Next Year | N/A | $79.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 191.30 | ★ 588.40 |
| 52 Week Low | $0.60 | $0.62 |
| 52 Week High | $3.07 | $1.70 |
Technical Indicators
Market Signals| Indicator | MMA | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 51.15 | 39.03 |
| Support Level | $1.24 | $0.65 |
| Resistance Level | $1.47 | $0.68 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 46.42 | 31.73 |
Price Performance
Historical ComparisonAbout MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.